Stockscreener 앱 받기
34.22
4.51%
-1.555
전일 마감가:
$35.77
열려 있는:
$35.485
하루 거래량:
549.38K
Relative Volume:
0.38
시가총액:
$1.30B
수익:
$117.67M
순이익/손실:
$-1.88B
주가수익비율:
-0.5653
EPS:
-60.5369
순현금흐름:
$-621.36M
1주 성능:
-7.43%
1개월 성능:
+53.53%
6개월 성능:
+145.58%
1년 성능:
+0.00%
1일 변동 폭
$32.76
$35.56
1주일 범위
$32.41
$37.35
52주 변동 폭
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
명칭
Grail Inc
전화
(833) 694-2553
주소
1525 O'BRIEN DRIVE, MENLO PARK
GRAL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
34.14 | 1.30B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
423.56 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
199.03 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
478.11 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.08 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.94 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Canaccord Genuity | Buy |
| 2024-11-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-10-17 | 개시 | Guggenheim | Neutral |
Grail Inc 주식(GRAL)의 최신 뉴스
Why GRAIL, Inc. (GRAL) is Surging in 2025 - Insider Monkey
GRAIL to Announce First Quarter 2025 Financial Results - The Victoria Advocate
CEO Sam Hazen on where technology will be HCA's 'holy grail' - The Business Journals
GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting - PR Newswire
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Benzinga
Opinion | The FTC vs. the War on Cancer - WSJ
This Cancer Test Could Become Routine—and a Big Seller, Says Analyst - Barron's
Canaccord starts Grail with a Buy, sees ‘solid upside’ - TipRanks
Canaccord sets $32 target on GRAIL stock with buy rating By Investing.com - Investing.com Nigeria
Canaccord Genuity Initiates GRAIL at Buy With $32 Price Target - marketscreener.com
Canaccord sets $32 target on GRAIL stock with buy rating - Investing.com
GRAIL, Inc. (GRAL): A Bull Case Theory - Insider Monkey
Form DEF 14A GRAIL, Inc. For: May 29 - StreetInsider
GRAIL's Galleri Progresses While Back In Accumulation Levels - Seeking Alpha
AI-Powered Studio GRAiL Launched By Davide Bianca & Jeff Krelitz - Deadline
How Does GRAIL Benefit From The Proposed MCED Legislation? (NASDAQ:GRAL) - Seeking Alpha
Multi-Cancer Early Detection Market Critical Analysis with Expert Opinion| GRAIL, Natera, Elypta - openPR.com
Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses – Great Science, Risky Bet! - Yahoo Finance
Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion deal - MarketScreener
A Sydney company’s laser focus on energy’s holy grail - @AuManufacturing
Opinion | One ‘Monopoly’ That Could Save Your Life - The Wall Street Journal
Is GRAIL Stock About to Skyrocket? - timothysykes.com
GRAIL Careers, Perks + Culture - Built In
Debate Over Multi-Cancer Screening Tests Shifts Pending Grail Randomized Trial Results - GenomeWeb
FDA approval remains Holy Grail for Aussie biotechs - NT News
Biocurious: FDA approval remains the Holy Grail for ASX life science stocks - Stockhead
Grail price target raised to $20 from $16 at Morgan Stanley - TipRanks
Have Insiders Sold GRAIL Shares Recently? - Simply Wall St
Jim Cramer On Netflix, Inc. (NFLX) – Subscription Is the Holy Grail—Netflix Is Doing Very Well! - Insider Monkey
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Grail president Joshua Ofman sells $65,800 in common stock By Investing.com - Investing.com Australia
Grail CEO Robert Ragusa sells $237,976 in stock By Investing.com - Investing.com Canada
Grail CEO Robert Ragusa sells $237,976 in stock - Investing.com India
Grail president Joshua Ofman sells $65,800 in common stock - Investing.com
Oppenheimer & Co. Inc. Invests $190,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Rhumbline Advisers Makes New Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
New York State Common Retirement Fund Makes New $59,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
Grail’s Stock Surge: An Eye on Future Moves - timothysykes.com
GRALGrail Inc Latest Stock News & Market Updates - StockTitan
Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025? - Yahoo Finance
Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In - Insider Monkey
Ieq Capital LLC Acquires Shares of 19,874 Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Grail (NASDAQ:GRAL) Trading 9.8% HigherWhat's Next? - MarketBeat
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
How GRAIL's Latest Employee Stock Grants Reveal Its Talent Acquisition Strategy - Stock Titan
Grail goes ‘Grey’s’: Actor Kate Walsh joins awareness campaign for multi-cancer early detection testing - FiercePharma
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing - Kilgore News Herald
Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability - MSN
GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey
Grail Inc (GRAL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):